Xspray Pharma: SEK300m rights issue announced - Redeye

Today Xspray announced a SEK300m rights issue. The capital injection came as no surprise and was partly already included in our valuation, but today’s announcement was more significant in size than we had anticipated. We adjust our assumptions accordingly.

Länk till analysen i sin helhet: https://www.redeye.se/research/900805/xspray-pharma-sek300m-rights-issue-announced?utm_source=finwire&utm_medium=RSS